Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients with Cirrhosis

Liver

This clinical trial studies how well contrast-enhanced ultrasound imaging works in diagnosing liver cancer in patients with cirrhosis. Diagnostic procedures, such as contrast-enhanced ultrasound imaging, may help find and diagnose liver cancer.
Liver
N/A
Planz, Virginia
NCT03318380
VICCGI19104

Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients with Prostate Cancer

Prostate

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.
Prostate
II
Planz, Virginia
NCT03697148
ECOGUROEA8171

Metabolism Informed Smoking Treatment in Medicaid and Medicare Patients: The MIST RCT

Miscellaneous

Miscellaneous
III
Tindle, Hilary
NCT04590404
VICCTHO2046

A Phase 2 Study of Cabozantinib in combination with Atezolizumab as Neoadjuvant Treatment for muscle-invasive Bladder Cancer (ABATE)

Bladder

Bladder
II
Davis, Nancy
NCT04289779
VICCURO2044

Early Onset Pulmonary Events in Patients with Non-Small Lung Cancer or Other Cancers Taking Brigatinib or Other TKIs

Multiple Cancer Types

This phase II trial studies early onset pulmonary events in patients with non-small lung cancer and other cancers taking brigatinib or other TKIs. Severe side effects, including trouble breathing, coughing, pneumonia, and inflammation of the lungs (pneumonitis), have been seen in patients taking brigatinib. This study is being done to watch patients taking brigatinib and compare that experience with patients taking other drugs that also target ALK or ROS1 to study how often events like these occur. This study is also being done to observe patients who stopped brigatinib temporarily because of a suspected early onset pulmonary event, but then restarted brigatinib at the same dose to assess what experience they have.
Lung, Non Small Cell
II
Iams, Wade
NCT03389399
VICCTHO1885

Wren Melanoma Study

Melanoma

Melanoma
N/A
Kauffmann, Rondi
NCT03267381
VICCMEL1783

The COVID-19 and Cancer Consortium (CCC19) Registry

Miscellaneous

Miscellaneous
N/A
Warner, Jeremy
NCT04354701
VICCMD2032

Islet Cell and ST2 Axis Dysregulation in Post-Transplant Diabetes Mellitus

Not Available
N/A
Engelhardt, Brian
NCT03415139
VICCCTT1836

Inherited CAncer REgistry (ICARE) Initiative

Miscellaneous

Miscellaneous
N/A
Pal, Tuya
NCT03231891
VICCMD1712

A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants with RCC (U03): Substudy 03B

Not Available
I/II
Beckermann, Kathryn
NCT04626518
VICCUROP2070

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: